Third, genetic polymorphisms of 5-HT2C, leptin and leptin receptor have been proven to influence weight gain and metabolic syndrome during clozapine treatment16,55; however, these pharmacogenetic parameters were not investigated in this study. This evidence concerns the gene LEPR and metabolic syndrome.